NEUROGENETIC PHARMACEUTICALS
Neurogenetic Pharmaceuticals, Inc. (NGP) is a biopharmaceutical discovery and development company founded in 2009 which is focused on developing innovative drug therapies for use in the treatment of neurodegenerative disorders such as Alzheimer’s disease. Based in San Diego, Calif., the company’s next objective is to obtain an Investigational New Drug approval for its clinical candidate, NGP 555. This compound is expected to prevent the deposition of amyloid plaques in the brain, thereby pre... cluding neuronal cell death and the dementia associated with AD. Future clinical trials will utilize specific Αβ biomarkers and/or brain scanning as an early diagnostic and to monitor drug efficacy in clinical trials. NGP licensed the GSM intellectual property from TPTX and expanded its portfolio to include issued patents in the US, Europe, China, India, Japan, Australia, and other countries.
NEUROGENETIC PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
Del Mar, California, United States
Country:
United States
Website Url:
http://www.neurogeneticpharmaceuticals.com
Total Employee:
1+
Status:
Active
Contact:
(858)735-5892
Email Addresses:
[email protected]
Total Funding:
4.04 M USD
Technology used in webpage:
Google Analytics Apache Google Analytics Classic GoDaddy Network Solutions DNS
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Braegen Pharmaceutical
The company is developing drugs for neurodegenerative diseases including Alzheimer’s disease.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Employees Featured
Founder
Investors List
Abbott Biotech Ventures
Abbott Biotech Ventures investment in Venture Round - NeuroGenetic Pharmaceuticals
Official Site Inspections
http://www.neurogeneticpharmaceuticals.com Semrush global rank: 8.65 M Semrush visits lastest month: 274
- Host name: 157.44.180.107.host.secureserver.net
- IP address: 107.180.44.157
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "NeuroGenetic Pharmaceuticals"
NeuroGenetic Pharmaceuticals - Crunchbase Company Profile
Neurogenetic Pharmaceuticals, Inc. (NGP) is a biopharmaceutical discovery and development company founded in 2009 which is focused on developing innovative drug therapies for use in …See details»
Organization | NeuroGenetic Pharmaceuticals Inc
NeuroGenetic Pharmaceuticals Inc Report issue. For profit Phase 1. Founded: Del Mar CA United States (2009 ... Organization Overview. First Clinical Trial. 2015 NCT02534480. First …See details»
NeuroGenetic Pharmaceuticals, Inc. - LinkedIn
NeuroGenetic Pharmaceuticals is a privately held biotech company founded in 2009 with worldwide exclusive rights to a platform of gamma-secretase modulators. Our patented technology includes...See details»
NeuroGenetic Pharmaceuticals, Inc. - Drug pipelines, Patents, …
Explore NeuroGenetic Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 3 literature, Drug:NGP-555.See details»
NEUROGENETIC PHARMACEUTICALS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NEUROGENETIC PHARMACEUTICALS, INC. of Del Mar, CA. Get the latest business …See details»
NeuroGenetic Pharma - VentureRadar
NeuroGenetic Pharmaceuticals, Inc. (NGP), a biopharmaceutical discovery and development company founded in 2009, is developing innovative drug therapies for Alzheimer's disease. …See details»
NeuroGenetic Pharmaceuticals Inc - Company Profile and News
NeuroGenetic Pharmaceuticals Inc., is a biopharmaceutical company. The Company develops drugs for the prevention of neurodegenerative conditions.See details»
NeuroGenetic Pharmaceuticals - Overview, News & Similar
Who is NeuroGenetic Pharmaceuticals. NeuroGenetic Pharmaceuticals, Inc. (NGP) is a biopharmaceutical discovery and development company founded in 2009 which is focused on …See details»
NeuroGenetic Pharmaceuticals - PitchBook
Developer of neurodegenerative drugs designed to treat and prevent the conditions of Alzheimer's disease. The company's drugs are based on a state-of-the-art modulation of a key enzyme in the amyloid pathway called gamma …See details»
NeuroGenetic Pharmaceuticals - Funding, Financials, Valuation
Neurogenetic Pharmaceuticals is engaged in the R&D of therapeutics for neurodegenerative disorders such as Alzheimer’s disease.See details»
NeuroGenetic Pharmaceuticals - Products, Competitors, Financials ...
Neurogenetic Pharmaceuticals is a biopharmaceutical discovery and development company focused on developing drug therapies for use in the treatment of neurodegenerative disorders …See details»
NeuroGenetic Pharmaceuticals Company Profile - Craft
NeuroGenetic Pharmaceuticals is a biotechnology company committed to the discovery and development of drugs for the prevention of neurodegenerative conditions. It leverages a …See details»
NeuroGenetic Pharmaceuticals - Crunchbase
Apellis, Idera, Adamas, and Arrowhead focus on developing novel therapeutics and drug delivery technologies for various diseases, while Braegen Pharmaceutical specifically targets …See details»
NeuroGenetic Pharmaceuticals Completes Phase 1 Clinical Trials …
Jan 9, 2017 · NeuroGenetic Pharmaceuticals, Inc. (NGP), a privately held biopharmaceutical company focused on Alzheimer’s disease (AD) therapeutics, has completed Phase 1 clinical …See details»
CEO and Chairman - NeuroGenetic Pharmaceuticals - LinkedIn
View William Comer’s profile on LinkedIn, the world’s largest professional community. William has 2 jobs listed on their profile. See the complete profile on LinkedIn and discover William’s...See details»
NGP 555, a γ-Secretase Modulator, Lowers the Amyloid ... - PubMed
Methods: Using amyloid biomarkers, chemical modeling, mouse behavioral models, and drug development techniques we investigate the properties of NGP 555, a clinical-stage γ …See details»
NeuroGenetic Pharmaceuticals - Contacts, Employees, Board …
NeuroGenetic Pharmaceuticals has 3 current employee profiles, including Founder Steven Wagner. Neurogenetic Pharmaceuticals is engaged in the R&D of therapeutics for …See details»
Gene-based therapies for neurodegenerative diseases - Nature
Feb 1, 2021 · In this Review, we first discuss the promises and challenges surrounding gene-based therapies for neurodegenerative diseases and then summarize the repertoire of gene …See details»
Advances in gene therapy for neurogenetic diseases: a brief review ...
Nov 27, 2021 · Viral vectors delivery, antisense oligonucleotides, gene editing, RNA interference, and burgeoning viroid delivery technique are promising gene therapy strategies, and …See details»
Neurogenetics: Advancing the “Next-Generation” of Brain Research
In this essay, we will outline the gains and the challenges of neurogenetic disease-oriented research.See details»